BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 26901912)

  • 21. Localized left atrial administration of tPA for the treatment of mechanical mitral valve thrombosis.
    Desai S; Kavinsky C
    Catheter Cardiovasc Interv; 2008 Aug; 72(2):151-5. PubMed ID: 18655116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful use of Tenecteplase in a patient with recurrence of prosthetic mitral valve thrombosis.
    Lahoti HA; Goyal BK
    Indian Heart J; 2015 Dec; 67 Suppl 2(Suppl 2):S55-7. PubMed ID: 26688154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombolytic therapy for prosthetic valve thrombosis: short- and long-term results.
    Gupta D; Kothari SS; Bahl VK; Goswami KC; Talwar KK; Manchanda SC; Venugopal P
    Am Heart J; 2000 Dec; 140(6):906-16. PubMed ID: 11099995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful fibrinolytic treatment of prosthetic heart valve thrombosis using streptokinase.
    Sakr SA; Abdel-Shakour H; Ramadan MM
    Acta Clin Belg; 2015 Jun; 70(3):159-66. PubMed ID: 25495280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombolysis for Left-Sided Prosthetic Valve Thrombosis: Short- and Long-Term Outcomes.
    Gupta S
    J Heart Valve Dis; 2016 Mar; 25(2):214-220. PubMed ID: 27989070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombolytic treatment for thrombosis of a mitral valve prosthesis during pregnancy.
    Nanas JN; Kontoyannis SA; Mitsibounas DN; Stamatelopoulos SF
    Intensive Care Med; 2001 Oct; 27(10):1668-9. PubMed ID: 11685310
    [No Abstract]   [Full Text] [Related]  

  • 27. Prosthetic mitral valve thrombosis: can fluoroscopy predict the efficacy of thrombolytic treatment?
    Montorsi P; Cavoretto D; Alimento M; Muratori M; Pepi M
    Circulation; 2003 Sep; 108 Suppl 1():II79-84. PubMed ID: 12970213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A successful case of repeat thrombolysis in prosthetic valve thrombosis.
    Naleem FS; Basavarajaiah S; Aggarwal R
    J Heart Valve Dis; 2010 Jan; 19(1):155-7. PubMed ID: 20329505
    [No Abstract]   [Full Text] [Related]  

  • 29. Use of tenecteplase in recurrent prosthetic valve thrombosis.
    Hariram V; Sharma NP
    J Heart Valve Dis; 2013 Nov; 22(6):872-3. PubMed ID: 24597413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prosthetic valve thrombosis presenting as an acute embolic myocardial infarction in a pregnant patient: issues on anticoagulation regimens and thrombolytic therapy.
    Varadarajan P; Isaeff D; Pai RG
    Echocardiography; 2006 Oct; 23(9):774-9. PubMed ID: 16999697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant tissue type plasminogen activator treatment of thrombosed mitral valve prosthesis during pregnancy.
    Fleyfel M; Bourzoufi K; Huin G; Subtil D; Puech F
    Can J Anaesth; 1997 Jul; 44(7):735-8. PubMed ID: 9232304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Guidelines for management of left-sided prosthetic valve thrombosis: a role for thrombolytic therapy. Consensus Conference on Prosthetic Valve Thrombosis.
    Lengyel M; Fuster V; Keltai M; Roudaut R; Schulte HD; Seward JB; Chesebro JH; Turpie AG
    J Am Coll Cardiol; 1997 Nov; 30(6):1521-6. PubMed ID: 9362411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of thrombolysis versus surgery as a first line therapy for prosthetic heart valve thrombosis.
    Keuleers S; Herijgers P; Herregods MC; Budts W; Dubois C; Meuris B; Verhamme P; Flameng W; Van de Werf F; Adriaenssens T
    Am J Cardiol; 2011 Jan; 107(2):275-9. PubMed ID: 21211605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The resolution of a mitral valve prosthesis thrombosis with low-dose plasminogen tissue activator and the role of Doppler echocardiographic monitoring].
    Bertoli D; Filorizzo G; Vivaldi F; Petacchi R
    G Ital Cardiol; 1994 May; 24(5):521-5. PubMed ID: 8076730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of unusual looking prosthetic mitral valve thrombosis treated with low dose slow infusion tPA.
    Bayar N; Arslan Ş; Köklü E; Kuş G
    Anadolu Kardiyol Derg; 2014 May; 14(3):297-9. PubMed ID: 24662584
    [No Abstract]   [Full Text] [Related]  

  • 36. Thrombolysis of prosthetic mitral valve thrombosis in an infant.
    Hage A; Jacques F; Chetaille P; Bourdages M; Cloutier K; Perron J; Houde C
    J Card Surg; 2017 May; 32(5):310-312. PubMed ID: 28463467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intra-atrial tissue plasminogen activator infusion for prosthetic valve thrombosis.
    Seltzer SM; Reed MD; Siwik ES
    Catheter Cardiovasc Interv; 2006 Jan; 67(1):139-41. PubMed ID: 16345053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of the outcome of thrombolytic therapy in prosthetic mitral valve thrombosis: a study of 62 events.
    Nagy A; Dénes M; Lengyel M
    J Heart Valve Dis; 2009 May; 18(3):268-75. PubMed ID: 19557981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prosthetic valve thrombosis: a regimen of treatment with low-dose and longer-course using recombinant tissue-type plasminogen activator is a promising protocol.
    Cáceres-Lóriga FM; Pérez-López H; Morlans-Hernández K
    J Thorac Cardiovasc Surg; 2008 Oct; 136(4):1104-5. PubMed ID: 18954672
    [No Abstract]   [Full Text] [Related]  

  • 40. Status of the Epicardial Coronary Arteries in Non-ST Elevation Acute Coronary Syndrome in Patients with Mechanical Prosthetic Heart Valves (from the TROIA-ACS Trial).
    Yesin M; Karakoyun S; Kalçık M; Gürsoy MO; Gündüz S; Astarcıoğlu MA; Bayam E; Cerşit S; Güner A; Özkan M
    Am J Cardiol; 2018 Aug; 122(4):638-644. PubMed ID: 29970239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.